Digoxin vs Nivolumab

Digoxin vs Nivolumab: Overview

This comparison examines the pharmacological differences between Digoxin and Nivolumab.

Mechanism of Action

Digoxin: Inhibits Na+/K+-ATPase, increasing intracellular calcium.

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Digoxin — 36-48 hours; Nivolumab — 27 days.

Chemical Properties

Molecular Formula: Digoxin — C41H64O14.

Molecular Weight: Digoxin — 780.9430 g/mol.

Type: Digoxin — Small molecule; Nivolumab — Antibody.